Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × UNKNOWN × Temozolomide × Clear all

Phase

Phase 2 3 Phase NA 1 Phase 3 1

Status

Sponsor Class

OTHER 28 INDUSTRY 26 NETWORK 9 NIH 6 OTHER_GOV 2 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 1

Interventions

Paclitaxel 6 Radiotherapy 3 Epirubicin 3 Radiotherapy, Intensity-Modulated 2 Radiation Dose Hypofractionation 2 Radiation 2 Docetaxel 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Capecitabine 2 pegylated granulocyte colony-stimulating factor 1 nabiximols 1 aumolertinib 1 Zoledronic Acid 1 Vinorelbine 1 Temozolomide 1 TP protocol 1 Standard of Care 1 S 1 (combination) 1 Platinum 1 Pemetrexed 1 Neoadjuvant Therapy 1 Irinotecan 1 Granulocyte Colony-Stimulating Factor 1 Drug Therapy 1 Decitabine 1 Chemotherapy, Adjuvant 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03778541 2019-07-23

HFSRT With Concurrent TMZ for Large BMs

ChineseAMS

Phase 3 Unknown

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡